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FUNDAMENTAL CONSIDERATIONS IN THE STUDY 
OF DRUG ABUSE AND HIV HEALTH DISPARITIES
Challenges in Understanding Disparities in Drug 
Use and its Consequences 
Sandro Galea and Sasha Rudenstine 
ABSTRACT Racial/ethnic disparities in health have long been documented in a broad
range of medical conditions in the United States. For example, Blacks have higher HIV
incidence and AIDS-related mortality than do Whites. This article summarizes racial/
ethnic differences in drug use and its consequences in the United States and proposes
three key challenges to the study of disparities in drug use and its consequences. These
are (a) patterns of drug use and misuse are complex, with different patterns of use of
different drugs in different racial/ethnic groups; (b) racial/ethnic differences in use of
drugs are not always associated with comparable differences in the consequences of
drug use; and (c) the consequences of drug use are associated with drug use itself and
other social/economic circumstances. Each of these challenges is discussed, and sugges-
tions offered for future research that may help overcome them. 
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INTRODUCTION 
There is a long recorded history of drug use and misuse in human civilization.
Abuse of alcohol, the oldest known psychoactive drug, was well recorded in classi-
cal Greek and Roman times. Opium, first used medicinally more than 3,000 years
ago, is now recreationally used and abused. There is a substantial burden of drug
use and misuse, both to those individuals who use substances and to society at
large.1 However, the burden of drug-related morbidity and mortality is not borne
equally by all groups. In the past decade, substantial attention has been dedicated to
health disparities in the United States. Although, broadly speaking, “health dispari-
ties” refers to inequalities in health status between groups, most public health and
medical attention to this issue in the United States has focused on racial/ethnic dis-
parities in morbidity and mortality that persist despite many federal initiatives
aimed at reducing these disparities.2,3 
The National Survey on Drug Use and Health (NSDUH)4 provides a concise cross-
sectional description of the prevalence of drug use and the racial/ethnic disparities in
drug use and misuse nationwide. In the 2002 NSDUH data release, the prevalence of
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past month alcohol use in 2002 was higher among Whites (55.0%) compared with
American Indians/Alaska natives (44.7%), Blacks (44.7%), and Hispanics (42.8%).
Racial/ethnic differences in cigarette use were different than those noted for alcohol
use. More than one third (37.1%) of American Indians/Alaska Natives reported
past month smoking compared with 26.9% of Whites, 25.3% of Blacks, 23.0% of
Hispanics, and 17.7% of Asians. The prevalence of current illicit drug use varied
among the major racial/ethnic groups in 2002 with the highest rate among Ameri-
can Indians/Alaska natives (10.1%), followed by Blacks (9.7%), Whites, (8.5%),
Hispanics (7.2%), and Asians (3.5%).4 There are also substantial variations in the
prevalence of past month illicit drug use among Hispanic subgroups [Puerto Ricans
(10.0%), Mexicans (7.3%), Cubans (6.5%), and Central or South Americans
(5.0%)].4 
There is ample evidence of racial/ethnic disparities in the consequences of
both licit and illicit drug use. In the United States, the age-adjusted prevalence of
cirrhosis was 15.8 per 100,000 persons among Hispanics compared with 9.4 and
9.0 per 100,000 persons among Blacks and Whites, respectively.5 The conse-
quences of cigarette smoking are far reaching,6–11 and there are racial/ethnic dis-
parities in several morbidities that are related to cigarette use. For example, across
the United States in 2001, the age-adjusted prevalence of cardiovascular disease
mortality was 432.5 per 100,000 persons among Blacks compared with 321.6 and
252.0 per 100,000 persons among Whites and Hispanics, respectively. Lung can-
cer age-adjusted mortality was 63.4, 57.7, and 23.8 per 100,000 persons among
Blacks, Whites, and Hispanics, respectively in 2001.5 One of the principal conse-
quences of illicit drug use in the United States over the past two decades, particu-
larly injection drug use, has been HIV infection. During the course of the 1990s,
racial/ethnic disparities in HIV prevalence have been growing. Nationally, in
2001 age-adjusted AIDS mortality rate among Blacks was 23.2 per 100,000 per-
sons; this compared with 6.2 per 100,000 persons among Hispanics and 2.1 per
100,000 persons among Whites.12 
We acknowledge that socioeconomic disparities in health are inextricably linked
to racial/ethnic disparities and also have been the focus of much attention.13,14 This dis-
cussion, however, is limited to racial/ethnic disparities recognizing the complexity
inherent in the study of differences in drug use and its consequences. Reference is made
to socioeconomic factors, where relevant, as important covariates to consider when
studying racial/ethnic disparities in drug use. 
LITERATURE REVIEW METHODS 
The literature that may be considered relevant to the topic at hand is vast. The focus
of this review is limited to five drugs (cigarettes, alcohol, marijuana, cocaine, and
heroin) and five synonyms for drug use (substance use, injection drug use, illicit
drug use, drug abuse, and drug misuse). The published literature was identified by
using the MEDLINE database (National Library of Medicine, Bethesda, Maryland),
covering both United States and international studies that assessed disparities in
drug use. The search was limited to English language studies in biomedical research.
The study of drug use is interdisciplinary; however, although articles outside of the
medical and public health disciplines were included, the search was not comprehen-
sive in those areas. A full review encompassing disciplines outside medicine and
public health would be beyond the scope of this review. Keywords and terms used
for the search included primarily the following: cigarettes, marijuana, alcohol,
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cocaine, heroin, substance use, injection drug use, illicit drug use, drug misuse, drug
abuse, white, black, Hispanic, poor, rich, and socioeconomic status. Additional
studies were retrieved from reference lists.15 
CHALLENGES IN THE STUDY OF DRUG USE, MISUSE, AND 
ITS CONSEQUENCES 
Despite the relative ubiquity of drug use, the systematic study of disparities in drug
use and its consequences is in its infancy. Several recent publications have proposed
frameworks that may help explain the causes underlying health disparities,16 but the
application of these frameworks to drug use remains limited.17 Based on the review
of the literature, three particular aspects of drug use research are suggested that make
the study of disparities in drug use and its consequences challenging. This study
focuses particularly on methodological challenges in the study of disparities and their
consequences. It presents in the concluding section a summary of research directions
that may, to some extent, help researches to overcome some of these challenges. 
Patterns of Drug Use and Misuse are Complex with 
Different Patterns of Use of Different Drugs in Different 
Racial/Ethnic Groups 
Drug use (or misuse) is not a single behavior or pathology, but rather a heteroge-
nous group of behaviors and attendant pathologies, each potentially having dif-
ferent causes and modifying factors, and each being differentially distributed
between racial and ethnic groups. These differences preclude attempts to directly
compare drug use simply between racial and ethnic groups, and such compari-
sons, taken at face value, are simplistic and distort understanding of health dis-
parities. 
For example, although Whites have a higher prevalence of current alcohol
drinking, some studies have suggested that among drinkers, Blacks are more likely
to have a lifetime dependence on alcohol,18 whereas Whites are more likely to abuse
alcohol.18,19 As another example, for illicit substance use, most studies suggest that
the prevalence of marijuana use is higher among Blacks than among other racial/
ethnic groups,20–23 yet this is inconsistent across studies.24 Blacks have a later onset
of marijuana abuse and dependence, and a higher rate of abuse/dependence in
adulthood.19 In addition, Blacks are more likely to have used cocaine, with more
frequency, and to be dependent than Whites.23,25,26 However, in contrast, although
heroin use is more common among Whites than it is among other racial/ethnic
groups,23 there are reported differences in injection practices between racial and eth-
nic groups that can be associated with disparities in the consequences of injection
drug use.26 In one study of the prevalence of fatal accidental drug overdose, it was
shown that Blacks and Hispanics in New York City have had consistently higher
rates of overdose death over the past decade than Whites.26 
Therefore, it is difficult to discuss simple racial/ethnic disparities in “drug use”
in the same way as can be done, for example, on disparities in HIV incidence or in
AIDS mortality. Rather, the racial/ethnic patterns of use and misuse differ across
drugs and, not infrequently, racial/ethnic groups with higher prevalence of use have
lower likelihood of abuse or dependence of a drug. This observation suggests that it
is difficult to consider racial/ethnic and socioeconomic differences in drug use as a
whole and also that group differences in stages of drug use and misuse need to be
assessed to better understand drug use-related disparities.15 
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Simple Conceptions of “Race/Ethnicity” May be 
Inadequate for Describing Disparities in Drug Use 
Patterns 
As in most works concerned with racial/ethnic disparities in health, this article
focuses primarily on the differences between Whites, Blacks, Hispanics, American
Indians/Alaska Natives, and Asians. However, these classifications are themselves
limiting and mask intergroup differences in drug use that can both facilitate under-
standing of disparities in health and guide interventions. For example, although
Asians are consistently shown to have lower prevalence of alcohol use than other
racial/ethnic groups,27,28 within Asians, native Hawaiians have the higher alcohol
consumption rate, followed by Hapahaoles-Japanese; persons of Chinese ancestry
have the lowest prevalence of alcohol consumption.29 Similarly, although the preva-
lence of smoking for Hispanics is lower than that for Blacks or Whites, and the His-
panics who smoke tend to smoke fewer cigarettes a day,30–32 among Hispanics,
Puerto Ricans and Cuban Americans are more likely to smoke than Mexican
Americans.32–34 This is in contrast to illicit drug use, where a study of marijuana use
among high-school seniors showed that marijuana prevalence was higher among
Mexican Americans than among Puerto Ricans, although both these groups had
lower marijuana prevalence than Whites.27 A study of adolescents showed that the
highest prevalence of cocaine use was among Mexican Americans, followed by
Cuban Americans, both of whom had a greater likelihood of cocaine use than did
Whites.35 Although studies of intraethnic group differences are more limited in
other illicit drug use, recent work has shown that HIV/AIDS incidence is higher
among Puerto Rican injection drug users compared with other Hispanic drug
users.36 
Therefore, racial/ethnic differences in substance use that make use of broad cat-
egories of race/ethnicity are likely to miss important intragroup differences in rates
of drug use, misuse, and its consequences. While most studies do not enroll suffi-
cient numbers of persons from each racial/ethnic group to be able to assess intra-
group differences such as the ones summarized above, absent such intragroup
assessments, a comprehensive determination of the causes of group inequalities in
health will remain elusive. 
Racial/Ethnic Differences in Use of Drugs are Not Always 
Associated with Comparable Differences in 
Consequences of Drug Use 
Thus far, this discussion has focused on racial/ethnic disparities in drug use and its
consequences, and difficulties in measuring these disparities have been highlighted.
However, perhaps even more challenging, the relationship between the relative rates
of use and misuse of a particular drug between specific racial/ethnic groups is not
always commensurate with the relative rates of the consequences of that same drug
between groups. For example, as noted earlier, the NSDUH shows that the rates of
illicit drug use in 2002 were highest among American Indians/Alaska natives
(10.1%), followed by Blacks (9.7%), Whites, (8.5%), Hispanics (7.2%), and Asians
(3.5%).4 Illicit, particularly injection drug use, has been one of the key modes of
transmission of HIV infection. However, during the course of the 1990s, the rates
of HIV infection among Blacks have risen far more than that of other racial/ethnic
groups disproportionate to the documented differences in illicit drug use. Nation-
ally, in 2001, age-adjusted AIDS mortality rate among Blacks was 23.2 per 100,000
persons; this compared with 6.2 per 100,000 persons among Hispanics and 2.1 per
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100,000 persons among Whites.37 These discrepancies between disparities in drug
use and misuse and its potential consequences primarily reflect the multifactorial
nature of drug-related pathology, and the consequences of drug use are as much a
reflection of social/economic circumstances as they are of the drug use itself. 
At the simplest level, there are multiple individual circumstances that are
known to be associated with both the use of drugs and its consequences. For exam-
ple, access to treatment and quality of available treatment have been shown to be
associated with cessation of drug use as well as lower drug-related risk, including
drug overdose, and contracting HIV, in the case of injection drug use.38–40 In turn,
the quality of treatment received by persons with HIV is associated both with pro-
gression of AIDS41 and with AIDS-related mortality. Several studies have shown
that minorities are less likely to have consistent access to diverse forms of medical
care,6,42,43 including HIV-related services.43,44 Therefore, in addition to racial/ethnic
disparities in the use of drugs, there are important racial/ethnic differences in these
other factors that influence potential drug-related consequences, and the ultimate
disparities observed in drug-related pathology reflect both disparities in drug use as
well as racial/ethnic differences in these other, equally important determinants. 
Recent work also has considered the role of contextual factors, or factors in the
individual’s social or physical environment, and how that is associated both with
use and misuse of drugs and with the other social and economic circumstances that
determine drug-related consequences. For example, although the evidence is lim-
ited, area-level social and economic disadvantage may be associated with greater
likelihood of cigarette and alcohol use.45,46 However, area-level disadvantage has
also been associated with more limited access to health care services, particularly in
predominantly minority communities, potentially compounding racial/ethnic differ-
ences in drug-related consequences.47 
This observation suggests that understanding racial/ethnic differences in the
consequences of drug use will require an appreciation of the diverse racial/ethnic
patterns of drug use itself, complicated by the factors discussed earlier in this article.
Also required is an appreciation of the circumstances that contribute to morbidity
and mortality and that may be differentially associated with drug use itself across
racial/ethnic groups. 
DISCUSSION 
It has been shown that there are well-documented racial/ethnic and socioeconomic
differences in drug use, misuse, and their consequences. However, these differences
are complex, and racial/ethnic patterns of use and misuse vary for different drugs.
In addition, other individual and contextual factors contribute to the pathogenesis
of drug-related morbidity and mortality, making it difficult to generalize about the
differential burden of the consequences of drug use across racial/ethnic groups sim-
ply through an assessment of disparities in use or misuse. Recognizing these difficul-
ties in the study of disparities in drug use, three directions are recommended that
can help overcome the challenges in the field and help advance appreciation of the
racial/ethnic differences in drug use and its consequences. 
First, we contend that a more comprehensive, systematic, and comparative
study of group differences in use, misuse, and consequences of different drugs is
needed. Very few studies are designed in a manner that allows direct comparison,
and as such, comparing disparities in use and misuse across drugs requires cross-
study comparison that relies on each study’s internal and external validity. Suitably
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designed intrastudy comparisons can help clarify differences between groups and
generate hypotheses that can guide etiological research. Absent such studies,
researchers and practitioners need to be immensely cautious when drawing general-
izations about patterns and differences between racial and ethnic groups of drug
use/misuse. Although much of the research that focuses on racial/ethnic disparities
in health is motivated by an appreciation of the disproportionate burden of pathol-
ogy borne by minority groups in the United States, this general pattern is not neces-
sarily the case for drug use/misuse, as discussed in this article. Given the stigma
associated with use and misuse of certain drugs,48 it is important that the study of
drug use/misuse and its consequences avoids oversimplification about group differences
and explicitly frames the known group differences with a focus on understanding
the reasons for these differences. 
Second, the study of drug use and its consequences clearly suggests the need
both for moving beyond simple racial and ethnic classifications to more nuanced
racial and ethnic categories that recognize the ever increasing complexity of life in
the United States and for studies that are designed to allow meaningful comparisons
of differences in drug use/misuse and its consequences within specific racial/ethnic
groups. Therefore, studies that oversample minority groups or that specifically
focus on assessing, for example, different groups of Hispanics, are warranted to
enable careful documentation of differences within these racial/ethnic groups and to
shed light on potential mechanisms underlying these differences. 
Third, as the two directions presented above suggest, there is a pressing need
for the field to move beyond description of differences in rates of drug use/misuse
and drug-related consequences to studies that consider explanations of these differ-
ences. Drug use and misuse do not occur in a vacuum, but rather are embedded
within an individual and a social context. There are few studies that have assessed
how a range of individual and social determinants modify or mediate the relation-
ship between race and ethnicity, drug use, and its consequences. To develop a com-
prehensive model that establishes why differences in drug use and misuse exist and
how these differences manifest in differential morbidity and mortality, there will be
a need to move toward a multifactorial model that considers race/ethnicity as part
of a more comprehensive causal framework. 
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